» Articles » PMID: 37850169

Ultrasound-Mediated Drug Delivery: Sonoporation Mechanisms, Biophysics, and Critical Factors

Overview
Journal BME Front
Date 2023 Oct 18
PMID 37850169
Authors
Affiliations
Soon will be listed here.
Abstract

Sonoporation, or the use of ultrasound in the presence of cavitation nuclei to induce plasma membrane perforation, is well considered as an emerging physical approach to facilitate the delivery of drugs and genes to living cells. Nevertheless, this emerging drug delivery paradigm has not yet reached widespread clinical use, because the efficiency of sonoporation is often deemed to be mediocre due to the lack of detailed understanding of the pertinent scientific mechanisms. Here, we summarize the current observational evidence available on the notion of sonoporation, and we discuss the prevailing understanding of the physical and biological processes related to sonoporation. To facilitate systematic understanding, we also present how the extent of sonoporation is dependent on a multitude of factors related to acoustic excitation parameters (ultrasound frequency, pressure, cavitation dose, exposure time), microbubble parameters (size, concentration, bubble-to-cell distance, shell composition), and cellular properties (cell type, cell cycle, biochemical contents). By adopting a science-backed approach to the realization of sonoporation, ultrasound-mediated drug delivery can be more controllably achieved to viably enhance drug uptake into living cells with high sonoporation efficiency. This drug delivery approach, when coupled with concurrent advances in ultrasound imaging, has potential to become an effective therapeutic paradigm.

Citing Articles

Enhanced model antigen retention in tissue through topical high-frequency ultrasound treatment.

Heo D, Kim H, Katagiri W, Yoon C, Lim H, Kim C Biomed Eng Lett. 2025; 15(2):273-282.

PMID: 40026896 PMC: 11871201. DOI: 10.1007/s13534-024-00445-5.


Nanomedicine's shining armor: understanding and leveraging the metal-phenolic networks.

Tang Z, Huang Z, Huang Y, Huang M, Liu H, Du J J Nanobiotechnology. 2025; 23(1):158.

PMID: 40025537 PMC: 11874145. DOI: 10.1186/s12951-025-03210-7.


Flow rate modulates focused ultrasound-mediated vascular delivery of microRNA.

He S, Singh D, Helfield B Mol Ther Nucleic Acids. 2025; 36(1):102426.

PMID: 39850318 PMC: 11754011. DOI: 10.1016/j.omtn.2024.102426.


Recent Advances and Future Directions in Sonodynamic Therapy for Cancer Treatment.

Datta P, Moolayadukkam S, Chowdhury D, Rayes A, Lee N, Sahu R BME Front. 2024; 2024:0080.

PMID: 39735354 PMC: 11671681. DOI: 10.34133/bmef.0080.


Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy.

Njoku G, Forkan C, Soltysik F, Nejsum P, Pociot F, Yarani R Bioact Mater. 2024; 45:41-57.

PMID: 39610953 PMC: 11602541. DOI: 10.1016/j.bioactmat.2024.11.004.


References
1.
. Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine. J Ultrasound Med. 2000; 19(2):120-42, 154-68. PMC: 2041884. DOI: 10.7863/jum.2000.19.2.120. View

2.
Wang C, Yang C, Lin Y, Chen C, Huang K . Anti-inflammatory effect with high intensity focused ultrasound-mediated pulsatile delivery of diclofenac. Biomaterials. 2011; 33(5):1547-53. DOI: 10.1016/j.biomaterials.2011.10.047. View

3.
Dalecki D . Mechanical bioeffects of ultrasound. Annu Rev Biomed Eng. 2004; 6:229-48. DOI: 10.1146/annurev.bioeng.6.040803.140126. View

4.
Duan L, Yang L, Jin J, Yang F, Liu D, Hu K . Micro/nano-bubble-assisted ultrasound to enhance the EPR effect and potential theranostic applications. Theranostics. 2020; 10(2):462-483. PMC: 6929974. DOI: 10.7150/thno.37593. View

5.
Bouakaz A, Versluis M, de Jong N . High-speed optical observations of contrast agent destruction. Ultrasound Med Biol. 2005; 31(3):391-9. DOI: 10.1016/j.ultrasmedbio.2004.12.004. View